Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing plicamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Plicamycin poisoning |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Accidental plicamycin poisoning |
Causative agent (attribute) |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
|
Intentional plicamycin poisoning |
Causative agent (attribute) |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
|
Plicamycin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Plicamycin adverse reaction |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Allergy to plicamycin |
Causative agent (attribute) |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
|
Plicamycin overdose |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Accidental plicamycin overdose |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Intentional plicamycin overdose |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Plicamycin overdose of undetermined intent |
Causative agent (attribute) |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
|
Plicamycin 2.5 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Plicamycin (substance) |
Inferred relationship |
Some |
|
Accidental plicamycin poisoning |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Intentional plicamycin poisoning |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Allergy to plicamycin |
Causative agent (attribute) |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Product containing only plicamycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely plicamycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Plicamycin 2.5 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Plicamycin 2.5 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Plicamycin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |
Product containing plicamycin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Plicamycin (substance) |
Inferred relationship |
Some |
1 |